OBJECTIVE: To determine whether a high prevalence (55%) of Aβ deposition in a cohort of individuals remaining dementia-free into their 9th and 10th decades is associated with cognitive decline prior to imaging. METHODS: A total of 194 participants (mean age 85.5 years, range 82-95) who completed the Ginkgo Evaluation of Memory Study (GEMS) and remained dementia-free subsequently completed Pittsburgh compound B-PET imaging. We examined cross-sectional associations between Aβ status and performance on a broad neuropsychological test battery completed at GEMS entry 7-9 years prior to neuroimaging. We also longitudinally examined cognition over annual evaluations using linear mixed models. RESULTS: At GEMS screening (2000-2002), participants who were Aβ-positive in 2009 had lower performance on the Stroop test (p < 0.01) and Raven's Progressive Matrices (p = 0.05), with trend level difference for Block Design (p = 0.07). Longitudinal analyses showed significant slope differences for immediate and delayed recall of the Rey-Osterrieth figure, semantic fluency, and Trail-Making Test parts A and B, indicating greater performance decline prior to neuroimaging for Aβ-positive relative to Aβ-negative participants (ps < 0.05). CONCLUSIONS: Highly prevalent Aβ deposition in oldest-older adults is associated with cognitive decline in visual memory, semantic fluency, and psychomotor speed beginning 7-9 years prior to neuroimaging. Mean differences in nonmemory domains, primarily executive functions, between Aβ-status groups may be detectable 7-9 years before neuroimaging.
OBJECTIVE: To determine whether a high prevalence (55%) of Aβ deposition in a cohort of individuals remaining dementia-free into their 9th and 10th decades is associated with cognitive decline prior to imaging. METHODS: A total of 194 participants (mean age 85.5 years, range 82-95) who completed the Ginkgo Evaluation of Memory Study (GEMS) and remained dementia-free subsequently completed Pittsburgh compound B-PET imaging. We examined cross-sectional associations between Aβ status and performance on a broad neuropsychological test battery completed at GEMS entry 7-9 years prior to neuroimaging. We also longitudinally examined cognition over annual evaluations using linear mixed models. RESULTS: At GEMS screening (2000-2002), participants who were Aβ-positive in 2009 had lower performance on the Stroop test (p < 0.01) and Raven's Progressive Matrices (p = 0.05), with trend level difference for Block Design (p = 0.07). Longitudinal analyses showed significant slope differences for immediate and delayed recall of the Rey-Osterrieth figure, semantic fluency, and Trail-Making Test parts A and B, indicating greater performance decline prior to neuroimaging for Aβ-positive relative to Aβ-negative participants (ps < 0.05). CONCLUSIONS: Highly prevalent Aβ deposition in oldest-older adults is associated with cognitive decline in visual memory, semantic fluency, and psychomotor speed beginning 7-9 years prior to neuroimaging. Mean differences in nonmemory domains, primarily executive functions, between Aβ-status groups may be detectable 7-9 years before neuroimaging.
Authors: V L Villemagne; K E Pike; D Darby; P Maruff; G Savage; S Ng; U Ackermann; T F Cowie; J Currie; S G Chan; G Jones; H Tochon-Danguy; G O'Keefe; C L Masters; C C Rowe Journal: Neuropsychologia Date: 2008-02-14 Impact factor: 3.139
Authors: Joseph L Price; Daniel W McKeel; Virginia D Buckles; Catherine M Roe; Chengjie Xiong; Michael Grundman; Lawrence A Hansen; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Charles D Smith; Daron G Davis; Frederick A Schmitt; William R Markesbery; Jeffrey Kaye; Roger Kurlan; Christine Hulette; Brenda F Kurland; Roger Higdon; Walter Kukull; John C Morris Journal: Neurobiol Aging Date: 2009-04-18 Impact factor: 4.673
Authors: John C Morris; Catherine M Roe; Elizabeth A Grant; Denise Head; Martha Storandt; Alison M Goate; Anne M Fagan; David M Holtzman; Mark A Mintun Journal: Arch Neurol Date: 2009-12
Authors: Meryl A Butters; William E Klunk; Chester A Mathis; Julie C Price; Scott K Ziolko; Jessica A Hoge; Nicholas D Tsopelas; Brian J Lopresti; Charles F Reynolds; Steven T DeKosky; Carolyn C Meltzer Journal: Alzheimer Dis Assoc Disord Date: 2008 Jul-Sep Impact factor: 2.703
Authors: Ganesh M Shankar; Brenda L Bloodgood; Matthew Townsend; Dominic M Walsh; Dennis J Selkoe; Bernardo L Sabatini Journal: J Neurosci Date: 2007-03-14 Impact factor: 6.167
Authors: Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg Journal: JAMA Date: 2008-11-19 Impact factor: 56.272
Authors: C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne Journal: Neurology Date: 2007-05-15 Impact factor: 9.910
Authors: Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk Journal: Arch Neurol Date: 2008-11
Authors: Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Eric M McDade; William E Klunk; Ann D Cohen; Chester A Mathis; Steven T Dekosky; Julie C Price; Oscar L Lopez Journal: JAMA Neurol Date: 2014-05 Impact factor: 18.302
Authors: Patrick J Brown; Joel R Sneed; Bret R Rutherford; D P Devanand; Steven P Roose Journal: Int J Geriatr Psychiatry Date: 2013-10-03 Impact factor: 3.485
Authors: Neelesh K Nadkarni; Oscar L Lopez; Subashan Perera; Stephanie A Studenski; Beth E Snitz; Kirk I Erickson; Chester A Mathis; Robert D Nebes; Mark Redfern; William E Klunk Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Maria Dekhtyar; Kathryn V Papp; Rachel Buckley; Heidi I L Jacobs; Aaron P Schultz; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: Neuropsychologia Date: 2017-05-01 Impact factor: 3.139
Authors: Kristine A Wilckens; Dana L Tudorascu; Beth E Snitz; Julie C Price; Howard J Aizenstein; Oscar L Lopez; Kirk I Erickson; Brian J Lopresti; Charles M Laymon; Davneet Minhas; Chester A Mathis; Daniel J Buysse; William E Klunk; Ann D Cohen Journal: Neurobiol Aging Date: 2018-07-26 Impact factor: 4.673
Authors: Yujing Zhao; Dana L Tudorascu; Oscar L Lopez; Ann D Cohen; Chester A Mathis; Howard J Aizenstein; Julie C Price; Lewis H Kuller; M Ilyas Kamboh; Steven T DeKosky; William E Klunk; Beth E Snitz Journal: JAMA Neurol Date: 2018-01-01 Impact factor: 18.302
Authors: Ian M McDonough; Gérard N Bischof; Kristen M Kennedy; Karen M Rodrigue; Michelle E Farrell; Denise C Park Journal: Neurobiol Aging Date: 2016-06-25 Impact factor: 4.673
Authors: Kathryn V Papp; Elizabeth C Mormino; Rebecca E Amariglio; Catherine Munro; Alex Dagley; Aaron P Schultz; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: Neuropsychology Date: 2015-11-23 Impact factor: 3.295